Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Français (Suisse)
Italiano
Nederlands (Nederland)
Nederlands (België)
MARKETS
Equities
United States
North America
Europe
Asia
Middle East
More Equities
Indexes
S&P 500
DOW JONES
NASDAQ 100
EURO STOXX 50
NIKKEI 225
More Indexes
Currency / Forex
USD / EUR
USD / CAD
USD / MXN
USD / BRL
USD / INR
More Currencies
Commodities
GOLD
CRUDE OIL (WTI)
CRUDE OIL (BRENT)
SILVER
PLATINUM
More Commodities
Cryptocurrencies
BITCOIN
ETHEREUM
Trackers & ETF
Rankings and News
Advanced Search
NEWS
Latest News
Companies
Markets
Economy
Currency / Forex
Commodities
Interest Rates
Finance Pro.
Business Leaders
Cryptocurrencies
Cybersecurity
Economic Calendar
Listed companies
Analyst Reco.
Rumors
IPOs
Capital Markets Transactions
New Contracts
Profit Warnings
Appointments
Press Releases
Events
Security Transactions
Financial Calendar
Sector News
Energy
Basic Materials
Industrials
Consumer Cyclical
Consumer Non-Cyclical
Financials
Healthcare
Technology
Real Estate
Utilities
ANALYSIS
All Analysis
Must Read
Weekly market update
Stock Trading Strategies
STOCK PICKS
All Stock Picks
Subscribe
PORTFOLIOS
My Portfolio
Virtual Portfolios
MarketScreener Portfolios
USA Portfolio
European Portfolio
Asian Portfolio
WATCHLISTS
My Watchlists
Watchlists
My previous session
My most visited
Most popular
Investment Style
ESG stocks
Undervalued stocks
Yield stocks
Growth stocks
Momentum stocks
Trend-Following Stocks
Investment Themes
The Vegan Market
The future of mobility
Robotics
The Cannabis Industry
Biotechnology
Sin stocks
RANKINGS
Top News
Most Read News
Hot News
Top Fundamentals
Top Capitalization
Top Yield
Top PER
Top Consensus
Top Fundamentals
Top ranking ESG
Top Technicals
Top RSI
Unusual volumes
Top Gaps
Top STIM
Breakouts
Trends
Top Movers
Top USA
Top Canada
Top U.K.
Top Germany
Top Europe
Top Asia
SCREENERS
Investment Themes
Luxury
Boats
Europe's family businesses
The Vegan Market
Water
The Cannabis Industry
Technical Rankings
Oversold stocks
Overbought stocks
Close to resistance
Close to support
Accumulation Phases
Most volatile stocks
Fundamental Rankings
Top Investor Rating
Top Trading Rating
Top Consensus
Growth stocks
Yield stocks
Low valuations
Stock Screener Home
My Screeners
All my stocks
Watchlists
Virtual Portfolios
TOOLS
MarketScreener tools
Stock Screener
iPhone App
Expert tools
Stock Screener PRO
Portfolio Creator
Event Screener
Tools
Dynamic Chart
Financial Calendar
Economic Calendar
Sector Research
Currency Converter
ProRealTime Trading
OUR SERVICES
Our subscriptions
MarketScreener Portfolios
European Portfolio
USA Portfolio
Asian Portfolio
Our Stock Picks
Thematic Investment Lists
Stock Screener
Homepage
Equities
United States
Nasdaq
EDAP TMS S.A.
News
Summary
EDAP
US2683111072
EDAP TMS S.A.
(EDAP)
Add to my list
Report
Delayed Nasdaq -
03:57 2022-08-11 pm EDT
7.320
USD
-2.27%
08/03
EDAP TMS SA to Announce Second Quarter 2022 Financial Results on August 24th, 2022
GL
07/19
European ADRs Rise in Tuesday Trading
MT
07/18
European ADRs Move Higher in Monday Trading
MT
Summary
Quotes
Charts
News
Ratings
Calendar
Company
Financials
Consensus
Revisions
Summary
Most relevant
All News
Analyst Reco.
Other languages
Press Releases
Official Publications
Sector news
European ADRs Nudge Lower in Tuesday Trading
06/28/2022 | 11:04am EDT
Send by mail :
Name :
First name :
From
*
:
To
*
:
(You can enter multiple email addresses separated by commas)
Message :
*
Required fields
© MT Newswires 2022
Stocks mentioned in the article
Change
Last
1st jan.
ADAPTIMMUNE THERAPEUTICS PLC
-2.17%
2.25
-40.00%
ASCENDIS PHARMA A/S
10.16%
104.81
-22.09%
BICYCLE THERAPEUTICS PLC
-8.90%
25.91
-57.43%
CELLECTIS S.A.
6.46%
3.624
-51.29%
EDAP TMS S.A.
-2.27%
7.32
22.20%
ENDAVA PLC
0.02%
110.34
-34.29%
EQUINOR ASA
2.46%
362
49.77%
ERYTECH PHARMA S.A.
2.06%
1.29
-39.15%
FORWARD PHARMA A/S
3.59%
3.75
-37.19%
GRIFOLS, S.A.
0.87%
13.84
-17.99%
MEREO BIOPHARMA GROUP PLC
-4.96%
1.15
-28.13%
NUCANA PLC
-3.23%
1.5
-36.97%
PRUDENTIAL PLC
-0.42%
990
-22.32%
SHELL PLC
2.03%
2213.5
36.48%
TRIVAGO N.V.
2.94%
1.75
-19.72%
VERONA PHARMA PLC
8.26%
11.8
75.60%
All news about EDAP TMS S.A.
08/03
EDAP TMS SA to Announce Second Quarter 2022 Financial Results on August 24th, 2022
GL
07/19
European ADRs Rise in Tuesday Trading
MT
07/18
European ADRs Move Higher in Monday Trading
MT
07/18
EDAP Announces Focal One® HIFU Reimbursement Raised to Urology APC Level 6 Under CMS Ou..
GL
06/30
European ADRs Fall Sharply in Thursday Trading
MT
06/28
European ADRs Nudge Lower in Tuesday Trading
MT
06/28
EDAP's Focal One® HIFU to be Showcased at Two Major Robotics & Urology International Co..
GL
06/28
EDAP's Focal One® HIFU to be Showcased at Two Major Robotics & Urology International Co..
AQ
06/21
European ADRs Rise Sharply in Tuesday Trading
MT
06/14
EDAP holds a Symposium at 6th European Endometriosis Congress
GL
More news
Analyst Recommendations on EDAP TMS S.A.
05/19
Piper Sandler Adjusts Price Target on EDAP TMS to $11 From $13, Reiterates Overweight R..
MT
2021
HC Wainwright Adjusts EDAP TMS' Price Target to $11 from $12, Keeps Buy Rating
MT
2021
B. Riley Lowers EDAP TMS' PT to $10 from $13 After Q3 Revenue Miss, Cuts Outlook on Q4,..
MT
More recommendations
Financials (USD)
Sales 2022
55,9 M
-
-
Net income 2022
-3,19 M
-
-
Net Debt 2022
-
-
-
P/E ratio 2022
-74,4x
Yield 2022
-
Capitalization
245 M
245 M
-
Capi. / Sales 2022
4,38x
Capi. / Sales 2023
3,76x
Nbr of Employees
227
Free-Float
36,8%
More Financials
Chart EDAP TMS S.A.
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Full-screen chart
Technical analysis trends EDAP TMS S.A.
Short Term
Mid-Term
Long Term
Trends
Bullish
Neutral
Bullish
Technical analysis
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
More Financials
Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
7,32 $
Average target price
11,33 $
Spread / Average Target
54,8%
Consensus
EPS Revisions
Please enable JavaScript in your browser's settings to use dynamic charts.
More Estimates Revisions
Managers and Directors
Marc Oczachowski
Chief Operating Officer
Francois Dietsch
Manager-Internal Audit & Consolidation
Frederic Pech
Chief Operating Officer
Argil J. Wheelock
Independent Director
Robert Michiels
Independent Director
More about the company
Sector and Competitors
1st jan.
Capi. (M$)
EDAP TMS S.A.
22.20%
251
THERMO FISHER SCIENTIFIC
-11.22%
232 076
DANAHER CORPORATION
-11.51%
211 788
INTUITIVE SURGICAL, INC.
-33.80%
84 939
EDWARDS LIFESCIENCES CORPORATION
-19.83%
64 387
BOSTON SCIENTIFIC CORPORATION
-3.41%
59 927
More Results
Slave